Mettez-vous hors ligne avec l'application Player FM !
BC 034 – Rivaroxaban et aspirine suite à une revascularisation pour maladie vasculaire artérielle périphérique (étude VOYAGER PAD).
Série archivée ("Flux inactif" status)
When? This feed was archived on August 20, 2023 01:52 (). Last successful fetch was on June 27, 2023 03:37 ()
Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 308806290 series 3020671
Dans cette 34e baladodiffusion, les Drs Luc Lanthier et Gabriel Huard discutent de l’efficacité du rivaroxaban dans le traitement des sujets avec maladie vasculaire artérielle périphérique post-revascularisation, en plus de réviser la littérature médicale de mai 2020.
Quiz clinique (1min03), étude principale (1min31), critique (20min11), autres articles (29min53), réponse au quiz clinique (33min15)
Référence principale
Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020;382(21):1994-2004. PubMed PMID: 32222135.
Articles associés
Creager MA. A Bon VOYAGER for Peripheral Artery Disease. N Engl J Med. 2020;382(21):2047-8. PubMed PMID: 32433842.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017;377(14):1319-30. PubMed PMID: 28844192.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219-29. PubMed PMID : 29132880.
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, et al. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 2019;157(2):403-12. PubMed PMID: 31054846.
https://www.inspq.qc.ca/sites/default/files/publications/2446_portrait_maladies_vasculaires.pdf
Autres articles d’intérêt
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2020;382(20):1883-93. PubMed PMID: 32222134.
Samama CM, Laporte S, Rosencher N, Girard P, Llau J, Mouret P, et al. Rivaroxaban or or Enoxaparin in Nonmajor Orthopedic Surgery. N Engl J Med. 2020;382(20):1916‐1925. PubMed PMID: 32223113.
Thiruganasambandamoorthy V, Sivilotti MLA, Le Sage N, Yan JW, Huang P, Hegdekar M, et al. Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. JAMA Intern Med. 2020;180(5):1‐8. PubMed PMID : 32202605.
Thiruganasambandamoorthy V, McRae AD, Rowe BH, Sivilotti MLA, Mukarram M, Nemnom MJ, et al. Does N-Terminal Pro-B-Type Natriuretic Peptide Improve the Risk Stratification of Emergency Department Patients With Syncope? Ann Intern Med. 2020;172(10):648-55. PubMed PMID : 32340039.
Guides de pratique
Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, et al. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36(5):596-624. PubMed PMID: 32389335.
Hiremath S, Sapir-Pichhadze R, Nakhla M, Gabor JY, Khan NA, Kuyper LM, et al. Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension. Can J Cardiol. 2020;36(5):625-34. PubMed PMID: 32389336.
Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(9):e56-e69. PubMed PMID: 32283960.
Référence du quiz clinique
Quinn KL, Stall NM, Yao Z, Stukel TA, Cram P, Detsky AS, et al. The risk of death within 5 years of first hospital admission in older adults. CMAJ. 2019;191(50):E1369-E77. PubMed PMID: 31844021.
50 episodes
Série archivée ("Flux inactif" status)
When? This feed was archived on August 20, 2023 01:52 (). Last successful fetch was on June 27, 2023 03:37 ()
Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 308806290 series 3020671
Dans cette 34e baladodiffusion, les Drs Luc Lanthier et Gabriel Huard discutent de l’efficacité du rivaroxaban dans le traitement des sujets avec maladie vasculaire artérielle périphérique post-revascularisation, en plus de réviser la littérature médicale de mai 2020.
Quiz clinique (1min03), étude principale (1min31), critique (20min11), autres articles (29min53), réponse au quiz clinique (33min15)
Référence principale
Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020;382(21):1994-2004. PubMed PMID: 32222135.
Articles associés
Creager MA. A Bon VOYAGER for Peripheral Artery Disease. N Engl J Med. 2020;382(21):2047-8. PubMed PMID: 32433842.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017;377(14):1319-30. PubMed PMID: 28844192.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219-29. PubMed PMID : 29132880.
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, et al. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 2019;157(2):403-12. PubMed PMID: 31054846.
https://www.inspq.qc.ca/sites/default/files/publications/2446_portrait_maladies_vasculaires.pdf
Autres articles d’intérêt
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2020;382(20):1883-93. PubMed PMID: 32222134.
Samama CM, Laporte S, Rosencher N, Girard P, Llau J, Mouret P, et al. Rivaroxaban or or Enoxaparin in Nonmajor Orthopedic Surgery. N Engl J Med. 2020;382(20):1916‐1925. PubMed PMID: 32223113.
Thiruganasambandamoorthy V, Sivilotti MLA, Le Sage N, Yan JW, Huang P, Hegdekar M, et al. Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. JAMA Intern Med. 2020;180(5):1‐8. PubMed PMID : 32202605.
Thiruganasambandamoorthy V, McRae AD, Rowe BH, Sivilotti MLA, Mukarram M, Nemnom MJ, et al. Does N-Terminal Pro-B-Type Natriuretic Peptide Improve the Risk Stratification of Emergency Department Patients With Syncope? Ann Intern Med. 2020;172(10):648-55. PubMed PMID : 32340039.
Guides de pratique
Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, et al. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36(5):596-624. PubMed PMID: 32389335.
Hiremath S, Sapir-Pichhadze R, Nakhla M, Gabor JY, Khan NA, Kuyper LM, et al. Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension. Can J Cardiol. 2020;36(5):625-34. PubMed PMID: 32389336.
Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(9):e56-e69. PubMed PMID: 32283960.
Référence du quiz clinique
Quinn KL, Stall NM, Yao Z, Stukel TA, Cram P, Detsky AS, et al. The risk of death within 5 years of first hospital admission in older adults. CMAJ. 2019;191(50):E1369-E77. PubMed PMID: 31844021.
50 episodes
Tous les épisodes
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.